The Anti-Inflammatory Stack: Curcumin, Omega-3

Prerequisite: Foundation Stack, you already have omega-3 in your Foundation build, which means you're one-third of the way there. The Anti-Inflammatory Stack combines three compounds that target three distinct inflammatory pathways. This isn't redundant stacking, each compound does something the others cannot. Curcumin inhibits NF-κB and COX-2 (the prostaglandin pathway). Boswellia inhibits 5-LOX (the leukotriene pathway). Omega-3 EPA and DHA produce resolvins, and DHA also protectins, that actively resolve inflammation once it starts (López-Vicario et al., 2016). Together, you get inflammatory suppression and resolution, a natural parallel to combining an NSAID, a leukotriene modifier, and a specialized pro-resolving mediator, with a gentler side-effect record in trials: curcuminoids caused fewer stomach side effects than NSAIDs in knee osteoarthritis (Bannuru et al., 2018), though not a risk-free one (see the liver note below).

As an Amazon Associate I earn from qualifying purchases.

Why three compounds? The three-pathway rationale

Inflammation is not one thing, it's a cascade of interconnected but distinct biochemical pathways. Most anti-inflammatory approaches (both pharmaceutical and natural) target only one. The Anti-Inflammatory Stack targets three:

The analogy: Think of inflammation like a fire. Curcumin reduces the fuel supply (NF-κB transcription of inflammatory genes). Boswellia cuts off a separate oxygen source (leukotriene production). Omega-3 sends in the fire brigade (resolvins that actively extinguish and resolve). You need all three for comprehensive fire management.

This is why taking just one anti-inflammatory compound, even a powerful one like curcumin, leaves inflammatory pathways uncovered. The meta-analyses for each individual compound show significant but partial effects. The rationale for combining them is mechanistic complementarity, not just "more is better."

What the combined evidence says: a 2018 meta-analysis of 11 knee osteoarthritis trials (1,009 patients) found both curcuminoid and boswellia formulations beat placebo for pain and function with no difference in safety, and curcuminoids matched NSAIDs with fewer stomach side effects. Its authors also judged the trials too small and too low in quality for firm clinical recommendations (Bannuru et al., 2018), so the three-pathway case is strong on mechanism and promising, not proven, on outcomes.

Compound 1: Curcumin, the inflammatory master switch

Curcumin targets NF-κB, the transcription factor that controls expression of over 500 inflammatory genes. When NF-κB is activated, it triggers production of TNF-α, IL-6, IL-1β, COX-2, and dozens of other inflammatory mediators. Curcumin inhibits this upstream, reducing the entire downstream cascade.

The evidence: Two 2016 meta-analyses found curcumin significantly reduced TNF-α across 8 RCTs (Sahebkar et al., 2016) and IL-6 across 9 trials (Derosa et al., 2016). A 2014 meta-analysis found significant CRP reduction when trials used bioavailability-improved forms for at least 4 weeks (Sahebkar, 2014), confirmed by a 2022 update (Gorabi et al., 2022). With Meriva, a 2010 Belcaro registry in osteoarthritis saw CRP in the high-CRP subgroup fall from 168 to 11.3 mg/L over three months (Belcaro et al., 2010), and an 8-month follow-up in 100 patients reported significant improvements in inflammatory markers versus control (Belcaro et al., 2010). For the full clinical breakdown, see our curcumin deep dive.

Critical: You must use a bioavailable form. Standard curcumin has <1% oral bioavailability. The three proven forms are Meriva (29x absorption, most clinical data, Cuomo et al., 2011), Longvida (65x free curcumin by its maker's figure, and the most brain-focused research, though no human study yet shows it crossing the blood-brain barrier; Gota et al., 2010), and CurcuWIN (46x absorption, Jäger et al., 2014). For this stack, Meriva is the default recommendation, broadest evidence base for systemic inflammation. See the buying guide for full product rankings.

Budget alternative: NOW Foods Curcumin with BioPerine ($0.33/day), same active compound at about a quarter of the price (625mg curcuminoids and 5mg BioPerine per capsule; price when we last checked in March 2026). The trade-off: piperine inhibits CYP3A4, the liver enzyme that clears many prescription drugs, in laboratory tests (Volak et al., 2008), although a small human study found no meaningful change in three test drugs (Volak et al., 2013). If you take medications, choose Meriva (piperine-free) instead.

Compound 2: Boswellia, the leukotriene blocker

Boswellia's AKBA inhibits 5-lipoxygenase (5-LOX), blocking production of leukotrienes, inflammatory mediators that drive cartilage destruction in osteoarthritis, bronchoconstriction in asthma, and mucosal inflammation in IBD. This is the pathway that curcumin, omega-3, and NSAIDs leave uncovered.

The evidence: A 2020 meta-analysis of 7 RCTs (545 patients) found boswellia significantly reduced pain and improved function in osteoarthritis (Yu et al., 2020). A trial in India found boswellia gum resin (350mg three times daily) put 82% of ulcerative colitis patients into remission at 6 weeks, against 75% on the drug sulfasalazine (Gupta et al., 1997), though a 52-week Crohn's trial found it kept no more patients in remission than placebo (Holtmeier et al., 2011). The gut trials used high doses, roughly 1,000 to 3,600mg/day of extract, and NIH notes that most boswellia studies are small and of low quality (NCCIH). For the full clinical breakdown, see our boswellia deep dive.

Why it matters for this stack: If you're taking curcumin for inflammation but not boswellia, you're still producing leukotrienes unchecked. Leukotrienes are the primary mediators of cartilage degradation in OA, this is why people with joint issues often plateau on curcumin alone. Adding boswellia covers the pathway curcumin misses.

Budget alternative: Doctor's Best Boswellia ($0.20/day), 250mg standardized to 65% boswellic acids. Take 2 capsules twice daily for the standard 1,000mg dose.

Compound 3: Omega-3, the active resolver

While curcumin and boswellia suppress inflammatory production, omega-3 does something neither can: it actively resolves existing inflammation. EPA is converted into E-series resolvins, and DHA into D-series resolvins, protectins and maresins, specialized pro-resolving mediators (SPMs) that signal immune cells to clean up inflammatory debris, restore tissue homeostasis, and return to baseline. Without adequate omega-3, inflammation lingers even after the initial trigger is removed.

The evidence: Omega-3's anti-inflammatory evidence is among the strongest of any supplement, multiple Cochrane reviews, hundreds of RCTs. The NIH's summary is more measured than the marketing: in rheumatoid arthritis trials, omega-3s generally reduced patients' use of anti-inflammatory drugs and corticosteroids but did not consistently ease painful joints or morning stiffness, and a 2020 Cochrane review of 86 trials found they cut triglycerides by about 15% and slightly lowered cardiovascular deaths (NIH ODS). If you're already running the Foundation Stack, you have this covered. For full product rankings, see our omega-3 roundup.

For this stack: Scale your dose up. Foundation recommends 1,000mg+ EPA+DHA. The Anti-Inflammatory Stack benefits from 2,000-3,000mg EPA+DHA daily, the dose range where anti-inflammatory effects are most pronounced. Consider Nordic Naturals Ultimate Omega 2X or take 2 servings of standard Ultimate Omega. Ultimate Omega 2X puts 2,000mg of EPA+DHA (1,125mg EPA, 875mg DHA) in a single 2-softgel serving, the full anti-inflammatory dose in half the softgels (NIH label database); two servings of standard Ultimate Omega give 2,200mg.

The complete dosing protocol

Daily timing schedule

Cycling

None required. Unlike adaptogens such as ashwagandha, none of the three Anti-Inflammatory Stack compounds show efficacy decline with continuous use. Clinical trials for curcumin and boswellia ran 6-12+ months of continuous supplementation with sustained benefits: Meriva for 8 months in osteoarthritis (Belcaro et al., 2010), and boswellia extract up to 1,000mg daily used safely in trials lasting up to 6 months (NCCIH). Omega-3 is a lifetime nutritional supplement with no cycling rationale. Run this stack continuously.

Onset expectations

• Week 1-2: Omega-3 benefits begin building (cell membrane incorporation takes ~4 weeks to peak)
• Week 2-4: Curcumin anti-inflammatory effects become measurable (CRP changes detectable)
• Week 4-8: Boswellia joint benefits become noticeable (OA trials show progressive improvement through week 12)
• Week 8-12: Full stack synergy, all three pathways operating at steady-state levels

Don't judge this stack before 8 weeks. If your primary concern is joint pain, give it the full 12 weeks before evaluating.

Cost breakdown

The budget build works. The active compounds are the same regardless of brand, the premium versions offer better bioavailability and third-party testing, but the budget build still covers all three inflammatory pathways. If budget is a constraint, start with the $0.65/day build and upgrade to premium forms if you can afford it later.

Who should run this stack

Ideal candidates:

• Osteoarthritis sufferers: This stack covers both COX-2 prostaglandins (curcumin) and 5-LOX leukotrienes (boswellia) that drive joint destruction, plus omega-3 resolvins for active repair. Multiple RCTs support each component individually for OA; the combination provides comprehensive pathway coverage
• Athletes with chronic joint stress: Pairs with the Athlete Stack. Omega-3 and curcumin are already in many performance protocols, boswellia adds the missing 5-LOX coverage for joint-heavy sports
• IBD / gut inflammation: Boswellia has direct evidence for UC and Crohn's. Omega-3 reduces gut mucosal inflammation. Curcumin suppresses NF-κB-driven cytokine production. This stack complements the Gut Restoration Stack for inflammation-dominant gut issues
• Chronic low-grade inflammation: Elevated CRP, metabolic syndrome, or anyone whose blood work shows inflammatory markers trending up
• Longevity protocol: Chronic inflammation ("inflammaging") is a primary driver of age-related disease. This stack slots into the Longevity Stack as the inflammation-targeting module

Who should NOT run this stack (or needs medical supervision)

Blood thinner users: All three compounds have mild anticoagulant or antiplatelet properties. Curcumin inhibits platelet aggregation. Boswellia has mild antiplatelet effects. Omega-3 at high doses can prolong bleeding time: the NIH puts that range at 2 to 15g a day of EPA and/or DHA, which this stack's 4-softgel protocol (2,200mg) reaches, although most research finds 3 to 6g a day of fish oil does not significantly change warfarin's effect (NIH ODS). Individually, these effects are mild. Combined, the additive effect warrants medical supervision if you take warfarin, aspirin, clopidogrel, or other blood thinners.

Liver warning (curcumin): the NIH notes that liver damage has been reported in some people taking curcumin formulations made more bioavailable, which is the class this stack recommends (Meriva, Longvida, CurcuWIN, piperine blends). In the US Drug-Induced Liver Injury Network's turmeric cases, injury appeared after 1 to 4 months and was strongly linked to the immune gene variant HLA-B*35:01 (Halegoua-DeMarzio et al., 2023). If you notice fatigue, nausea, poor appetite, dark urine or yellowing of the skin or eyes, stop the curcumin and talk with your health care provider (NCCIH); if you have liver disease, ask your doctor before starting.

Pre-surgery: Discontinue the entire stack 2 weeks before any scheduled surgery due to the combined anticoagulant effects.

Prescription medication users (if using BioPerine curcumin): Piperine in BioPerine formulations inhibits the CYP3A4 liver enzyme in laboratory tests, which could raise blood levels of drugs it clears (Volak et al., 2008). If you take prescription medications, either choose Meriva (piperine-free) or consult your doctor. This doesn't apply to boswellia or omega-3.

Gallbladder disease: Curcumin stimulates bile production. Avoid curcumin (but boswellia and omega-3 are fine) if you have gallstones or bile duct obstruction.

Pregnancy: Avoid supplemental curcumin and boswellia during pregnancy: turmeric supplements may be unsafe in pregnancy, and little is known about medicinal doses of boswellia in pregnancy or breastfeeding (NCCIH turmeric, NCCIH boswellia). Omega-3 at standard doses is generally considered safe and beneficial during pregnancy, consult your OB/GYN.

How this stack fits with other Health Britannica stacks

Foundation Stack overlap: Omega-3 is already in your Foundation build. You just need to add curcumin and boswellia, and potentially increase your omega-3 dose from 1,000mg to 2,000mg+ EPA+DHA.

Daily totals check: EPA+DHA at the aggressive protocol is 2,200mg (2,000mg with Ultimate Omega 2X), well under the 5g a day the FDA calls safe for supplements but inside the 2 to 15g range where the NIH says bleeding time may rise, so the blood-thinner note above applies (NIH ODS). Boswellia at one AprèsFlex capsule (100mg) sits far below the 1,000mg a day used safely for up to 6 months in trials (NCCIH). Curcumin: the Longevity Stack's curcumin is this curcumin, so if you run both, take one Meriva serving (2 capsules, 1g), not two. None of the three products contains a vitamin or mineral, so this stack adds nothing to the vitamin D, magnesium or zinc totals from your Foundation Stack.

Longevity Stack overlap: The Longevity Stack already includes curcumin and omega-3. Adding boswellia completes the anti-inflammatory trifecta. The Longevity Stack's CoQ10 and NMN/NR target different aging pathways (mitochondrial function, NAD+ decline), no overlap or interaction concerns.

Athlete Stack: The Athlete Stack benefits from this entire anti-inflammatory protocol for exercise recovery and joint protection. Curcumin (reduced CK markers), omega-3 (reduced DOMS), boswellia (joint protection during heavy training).

Gut Restoration Stack: For inflammation-dominant gut issues, this stack complements the Gut Restoration Stack's repair protocol (glutamine, DGL, probiotics). The Anti-Inflammatory Stack handles the upstream inflammation; Gut Restoration handles the downstream repair and reinoculation.

Adaptogen Stack: No direct overlap. The Adaptogen Stack (ashwagandha + rhodiola + holy basil) targets stress-driven inflammation through HPA axis modulation, a different layer than direct inflammatory pathway inhibition. They complement each other.

Sources

1. National Center for Complementary and Integrative Health. Turmeric. Accessed 19 October 2026.
2. National Center for Complementary and Integrative Health. Boswellia: Usefulness and Safety. Accessed 19 October 2026.
3. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. Accessed 19 October 2026.
4. Bannuru RR et al. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin Arthritis Rheum. 2018. Accessed 19 October 2026.
5. López-Vicario C et al. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. Eur J Pharmacol. 2016. Accessed 19 October 2026.
6. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014. Accessed 19 October 2026.
7. Sahebkar A et al. Curcumin downregulates human tumor necrosis factor-α levels. Pharmacol Res. 2016. Accessed 19 October 2026.
8. Derosa G et al. Effect of curcumin on circulating interleukin-6 concentrations. Pharmacol Res. 2016. Accessed 19 October 2026.
9. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Phytother Res. 2014. Accessed 19 October 2026.
10. Gorabi AM et al. Effect of curcumin on C-reactive protein: an updated meta-analysis of randomized controlled trials. Phytother Res. 2022. Accessed 19 October 2026.
11. Belcaro G et al. Product-evaluation registry of Meriva for the complementary management of osteoarthritis. Panminerva Med. 2010. Accessed 19 October 2026.
12. Belcaro G et al. Efficacy and safety of Meriva during extended administration in osteoarthritis patients. Altern Med Rev. 2010. Accessed 19 October 2026.
13. Cuomo J et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011. Accessed 19 October 2026.
14. Gota VS et al. Safety and pharmacokinetics of a solid lipid curcumin particle formulation. J Agric Food Chem. 2010. Accessed 19 October 2026.
15. Jäger R et al. Comparative absorption of curcumin formulations. Nutr J. 2014. Accessed 19 October 2026.
16. Volak LP et al. Curcuminoids inhibit multiple human cytochromes P450, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos. 2008. Accessed 19 October 2026.
17. Volak LP et al. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol pharmacokinetics. Br J Clin Pharmacol. 2013. Accessed 19 October 2026.
18. Halegoua-DeMarzio D et al. Liver Injury Associated with Turmeric: Ten Cases from the Drug-Induced Liver Injury Network. Am J Med. 2023. Accessed 19 October 2026.
19. Yu G et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020. Accessed 19 October 2026.
20. Gupta I et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997. Accessed 19 October 2026.
21. Holtmeier W et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease. Inflamm Bowel Dis. 2011. Accessed 19 October 2026.
22. Sengupta K et al. Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee. Int J Med Sci. 2010. Accessed 19 October 2026.
23. Dyerberg J et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010. Accessed 19 October 2026.
24. NIH Dietary Supplement Label Database. Nordic Naturals Ultimate Omega Lemon, label. Accessed 19 October 2026.
25. NIH Dietary Supplement Label Database. Nordic Naturals Ultimate Omega 2X Lemon, label. Accessed 19 October 2026.
26. NIH Dietary Supplement Label Database. NOW Turmeric Curcumin with BioPerine, label. Accessed 19 October 2026.
27. Thorne. Curcumin Phytosome, product facts and price. Accessed 19 October 2026.

Bottom line

Chronic inflammation drives virtually every age-related disease, cardiovascular disease, neurodegeneration, cancer, metabolic syndrome, autoimmune conditions, osteoarthritis. The Anti-Inflammatory Stack is Health Britannica's most comprehensive natural protocol for addressing it. Three compounds target three distinct inflammatory pathways: curcumin inhibits NF-κB and COX-2 (prostaglandin suppression), boswellia inhibits 5-LOX (leukotriene suppression), and omega-3 produces resolvins (active inflammation resolution). The evidence for each component individually is strong, multiple meta-analyses, hundreds of combined RCTs. The rationale for combining them is mechanistic, not just additive. At $0.65-2.69/day depending on your build, this is one of the highest-evidence, most cost-effective intervention stacks on the site. Start with the Foundation Stack, add curcumin and boswellia, scale your omega-3 dose up, and give it 8-12 weeks to reach full effect.